Skip to main content

Table 5 Prevalence of sarcopenia and sarcopenia categories according to FAS eGFR (ml/min/1.73m2) categories

From: Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria

  Non-sarcopenic (n = 1270) Sarcopenic (n = 150) p-value
FAS eGFR category No sarcopenia (n = 1114) Probable sarcopenia (n = 156) Confirmed sarcopenia (n = 65) Severe sarcopenia (n = 85)
≥90 (n = 26) 22 (84.6%) 4 (15.4%) 0.420
16 (61.5%) 6 (23.1%) 2 (7.7%) 2 (7.7%)  
60–89 (n = 553) 496 (89.7%) 57 (10.3%) 0.802
456 (82.5%) 40 (7.2%) 29 (5.2%) 28 (5.1%)  
45–59 (n = 480) 437 (91.0%) 43 (9.0%) 0.160
380 (79.2%) 57 (11.9%) 22 (4.6%) 21 (4.4%)  
30–44 (n = 253) 225 (89.0%) 28 (11.1%) 0.774
188 (74.3%) 37 (14.6%) 9 (3.6%) 19 (7.5%)  
15–29 (n = 108) 90 (83.3%) 18 (16.7%) 0.032
74 (68.5%) 16 (14.8%) 3 (2.8%) 15 (13.9%)  
≥60 (n = 1059) 955 (90.2%) 104 (9.8%) 0.119
852 (80.5%) 103 (9.7%) 53 (5.0%) 51 (4.8%)
< 60 (n = 361) 315 (87.3%) 46 (12.7%)
262 (72.6%) 53 (14.7%) 12 (3.3%) 34 (9.4%)
  1. eGFR Estimated glomerular filtration rate, FAS Full Age Spectrum